Human Papillomavirus Persistence in Young Unscreened Women, a Prospective Cohort Study

Department of Obstetrics and Gynaecology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
PLoS ONE (Impact Factor: 3.53). 11/2011; 6(11):e27937. DOI: 10.1371/journal.pone.0027937
Source: PubMed

ABSTRACT To evaluate hr-HPV persistence and associated risk factors in a prospective cohort of young unscreened women. Additionally, the relation between hr-HPV status and cytology/histology results is examined.
Two year follow-up of 235 out of 2065 young women (18-29 years), participating in a large, one year epidemiological study, with questionnaires, self-collected cervico-vaginal samples (Vibabrush), and SPF(10)LiPA for HPV detection. Only women hr-HPV positive at sample month 12 were invited for a second year of follow-up. After study follow-up, available cytology/histology data were requested from PALGA (the national network and registry of histo- and cytopathology in The Netherlands). These data were compared with available cytology/histology data of the month 12 hr-HPV negative women from the same cohort. 44.1% of the hr-HPV types detected at study month 12, persisted during follow-up. HPV types 45, 31, 16 and 18 were most likely to persist with percentages of 60.0%, 56.8%, 54.4%,and 50.0%, respectively. Compared to newly detected infections at month 12, infections present since 6 months or baseline had an increased risk to persist (OR 3.09 [95% CI: 1.74-5.51] and OR 4.99 [95% CI: 2.67-9.32], respectively). Other co-factors influencing persistence were, multiple HPV infections, smoking and multiple lifetime sexual partners. The percentage of women with a HSIL/CIN2+ (12.1%) in the persistent HPV group, was not significantly different (p = 0.107) from the 5.3% of the women who cleared the hr-HPV infection, but was significantly (p 0.000) higher than to the 1.6% of women in the hr-HPV negative control group.
We showed that HPV genotype, multiple infections, smoking, and multiple lifetime sexual partners are co-factors that increase the risk of hr-HPV persistency. Most importantly, we showed that hr-HPV infections are more likely to persist the longer they have been present and that women with a persistent hr-HPV infection have a high risk of HSIL/CIN2+ development.

Download full-text


Available from: Ruud L M Bekkers, Jul 18, 2015
  • Source
    • "The most significant risk factors in HPV infection include age and sexual activity [17]. Infection is most frequent in women between 20 and 40 years of age, with the peak of incidence between 15 and 25 years of age. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Human papillomavirus (HPV) belongs to the diverse group of sexually transmitted viruses that manifest affinity to the squamous epithelia of the skin and mucous membranes. Over 100 types of HPV have been described and identified in human tissues, and it has been proved that persistent infection with high-risk types of the virus (types 16 and 18 in particular) could lead to cervical cancer. High-risk HPV types have been found in approximately 70% of all cases of cervical cancer worldwide. The aim of this study was to describe the role of HPV in the process of neoplastic transformation in epithelial cells and to emphasize the prophylactic significance of vaccinations against the virus.
    03/2012; 21(2):235-44.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Vulvar squamous cell carcinoma (VSCC) is the fourth most common gynecological cancer. Based on etiology VSCC is divided into two subtypes; one related to high-risk human papilloma virus (HPV) and one HPV negative. The two subtypes are proposed to develop via separate intracellular signaling pathways. We investigated a suggested link between HPV infection and relapse risk in VSCC through in-depth protein profiling of 14 VSCC tumor specimens. The tumor proteomes were analyzed by liquid-chromatography tandem mass spectrometry. Relative protein quantification was performed by 8-plex isobaric tags for relative and absolute quantification. Labeled peptides were fractionated by high-resolution isoelectric focusing prior to liquid-chromatography tandem mass spectrometry to reduce sample complexity. In total, 1579 proteins were regarded as accurately quantified and analyzed further. For classification of clinical groups, data analysis was performed by comparing protein level differences between tumors defined by HPV and/or relapse status. Further, we performed a biological analysis on individual tumor proteomes by matching data to known biological pathways. We here present a novel analysis approach that combines pathway alteration data on individual tumor level with multivariate statistics for HPV and relapse status comparisons. Four proteins (signal transducer and activator of transcription-1, myxovirus resistance protein 1, proteasome subunit alpha type-5 and legumain) identified as main classifiers of relapse status were validated by immunohistochemistry (IHC). Two of the proteins are interferon-regulated and on mRNA level known to be repressed by HPV. By both liquid-chromatography tandem mass spectrometry and immunohistochemistry data we could single out a subgroup of HPV negative/relapse-associated tumors. The pathway level data analysis confirmed three of the proteins, and further identified the ubiquitin-proteasome pathway as altered in the high risk subgroup. We show that pathway fingerprinting with resolution on individual tumor level adds biological information that strengthens a generalized protein analysis.
    Molecular &amp Cellular Proteomics 04/2012; 11(7):M112.016998. DOI:10.1074/mcp.M112.016998 · 7.25 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The objective of this research was to evaluate the relationship of Ki-67 and telomerase expression with the progression of cervical intraepithelial neoplasia (GIN) and the physical state of the DNA of high-risk human papillomavirus (HR-HPV) types. A comparative study was done on 80 biopsies of human (female) cervical tissue, distributed in the following manner: 20 GIN-negative biopsies and 60 GIN-positive biopsies of varying grades. The detection of the proteins Ki-67 and telomerase was performed through immunohistochemistry; the detection of HR-HPV, by in situ hybridization. The expression of Ki-67 and telomerase increased with the progression of the GIN lesion (p < 0.001). The HR-HPV genome was detected in 75% of the cases with GIN, as well as in 20% of the tissues without histological lesions (p=0.001). A significant association was found between the increase in telomerase and Ki-67 expression and the integration of the DNA of HR-HPV. The overexpression of Ki-67, telomerase and the presence the integration of the DNA of HR-HPV are evidenced by more aggressive lesions that may progress to invasive carcinoma.
    Archives of Biological Sciences 01/2013; 65(1):81-90. DOI:10.2298/ABS1301081P · 0.61 Impact Factor
Show more